Vlad Ratziu

22PUBLICATIONS
114CO-AUTHORS
Medical biochemistry - lipidsMedical infection agents (incl. prions)Metabolic medicinePredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 24, 2026
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.

|Jan 07, 2026
MASLD as a complication of obesity must include liver risk stratification.

Mary E Rinella, Arun J Sanyal, Rohit Loomba

|Dec 31, 2025
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities.

Xiao-Dong Zhou, Qiong-Yue Fan, Christopher D Byrne

|Dec 17, 2025
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

Pierre-Antoine Soret, Virginie Steunou, Julien Hedou

|Jul 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.

Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi

|Jul 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis.

Maximilian Jara, Jenny Norlin, Mette Skalshøi Kjær

Pageof 4

Frequent Collaborators

7 joint publications

Arun J Sanyal

7 joint publications

Quentin M Anstee

7 joint publications

Jörn M Schattenberg

3 joint publications

Rohit Loomba